...
首页> 外文期刊>Urologic oncology >NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder
【24h】

NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder

机译:对于膀胱尿路上皮癌患者,NLR可以预测根治性膀胱切除术时的分期升级

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To evaluate the ability of preoperative neutrophil-lymphocyte ratio (NLR) to predict pathologic upstaging and nonorgan-confined (NOC) (≥pT3) disease. Methods and materials: After institutional review board approval, the records of consecutive patients undergoing radical cystectomy (RC) for urothelial carcinoma from 2002 to 2012 at the University of Wisconsin Hospital were reviewed. A total of 102 patients with NLR within 100 days of surgery were eligible for analysis. The primary outcome was difference in stage from preoperative assessment to time of RC. Differences in preoperative NLR between groups were evaluated with an unequal variance t test. A univariate analysis assessed whether NLR, preoperative stage, grade, associated lymphovascular invasion, preoperative hydronephrosis, gender, previous pelvic radiotherapy, previous intravesical bladder cancer treatments, or nodal stage were related to upstaging. Multivariate analyses were performed to evaluate the relationship of NLR to upstaging and relative organ-confined (≤pT2) and NOC disease. Results: Of 390 consecutive patients undergoing RC, 102 patients met study criteria. Overall, 55 (53.9%) patients were upstaged, 25 (25.5%) were unchanged, and 21 (20.6%) were downstaged. Fifty-one patients (50%) were upstaged to more advanced disease (≥pT3). NLR and preoperative hydronephrosis were significantly related to pathologic tumor staging. NLR, preoperative hydronephrosis, and preoperative tumor stage were significantly related to upstaging to NOC disease. Patients who were upstaged to≥pT3 demonstrated statistically significant greater NLRs (4.33±0.87) compared with patients who remained at≤pT2 stage (2.66±0.29) (P<0.001). Conclusions: Preoperative NLR is a simple measurement that can be used to identify high-risk patients who may be upstaged at the time of RC and may benefit from neoadjuvant chemotherapy.
机译:目的:评估术前嗜中性粒细胞-淋巴细胞比率(NLR)预测病理性升级和非器官限制(NOC)(≥pT3)疾病的能力。方法和材料:经过机构审查委员会的批准,回顾了2002年至2012年在威斯康星大学医院连续接受尿路上皮癌根治性膀胱切除术(RC)的患者的记录。手术100天内共有102例NLR患者符合分析条件。主要结果是从术前评估到RC时间的阶段差异。组间术前NLR的差异通过不等方差t检验进行评估。单因素分析评估了NLR,术前分期,等级,相关的淋巴血管浸润,术前肾积水,性别,以前的骨盆放疗,以前的膀胱内膀胱癌治疗或淋巴结转移是否与分期升级有关。进行多变量分析以评估NLR与上调和相对器官受限(≤pT2)和NOC疾病的关系。结果:在390名接受RC的连续患者中,有102名患者符合研究标准。总体而言,有55位(53.9%)的患者接受了升级手术,其中25位(25.5%)的患者未进行手术转移,有21位(20.6%)的患者接受了手术后转移。 51名患者(50%)升级为晚期疾病(≥pT3)。 NLR和术前肾积水与病理性肿瘤分期显着相关。 NLR,术前肾积水和术前肿瘤分期与NOC疾病升级有关。升级到≥pT3的患者与保持≤pT2阶段的患者(2.66±0.29)相比,在统计学上显示出更大的NLR(4.33±0.87)(P <0.001)。结论:术前NLR是一种简单的测量方法,可用于识别在RC时可能已升级并可能受益于新辅助化疗的高危患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号